Amphiregulin-Deficient Mice Develop Spasmolytic Polypeptide Expressing Metaplasia and Intestinal Metaplasia

Gastroenterology

Volumn 136, Issue 4, 2009, Pages 1288-1296

  Nam, Ki Taek ^a,b   Lee, Hyuk Joon ^a,b   Mok, Hoyin ^b   Romero Gallo, Judith ^b   Crowe Jr , James E ^b   Peek Jr , Richard M ^b   Goldenring, James R ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHIREGULIN; BETA CATENIN; KI 67 ANTIGEN; MUCIN 2; TRANSCRIPTION FACTOR PDX 1; TREFOIL PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LINEAGE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSOL; DISEASE PREDISPOSITION; GOBLET CELL; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; METAPLASIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPASMOLYTIC POLYPEPTIDE EXPRESSINE METAPLASIA; STOMACH DISEASE; STOMACH FUNDUS; STOMACH MUCOSA; TRANSGENIC MOUSE; WILD TYPE;

EID: 62949123532     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.12.037     Document Type: Article

References (45)

1. Karam S.M., and Leblond C.P. Dynamics of epithelial cells in the corpus of the mouse stomach. I. Identification of proliferative cell types and pinpointing of the stem cell. Anat Rec 236 (1993) 259-279
2. Karam S.M., and Leblond C.P. Dynamics of epithelial cells in the corpus of the mouse stomach. III. Inward migration of neck cells followed by progressive transformation into zymogenic cells. Anat Rec 236 (1993) 297-313
3. El-Zimaity H.M., Ota H., Graham D.Y., et al. Patterns of gastric atrophy in intestinal type gastric carcinoma. Cancer 94 (2002) 1428-1436
4. Correa P. A human model of gastric carcinogenesis. Cancer Res 48 (1988) 3554-3560
5. Filipe M.I., Munoz N., Matko I., et al. Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia. Int J Cancer 57 (1994) 324-329
6. Reis C.A., David L., Correa P., et al. Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res 59 (1999) 1003-1007
7. Taupin D., Pedersen J., Familari M., et al. Augmented intestinal trefoil factor (TFF3) and loss of pS2 (TFF1) expression precedes metaplastic differentiation of gastric epithelium. Lab Invest 81 (2001) 397-408
8. Goldenring J.R., and Nomura S. Differentiation of the Gastric Mucosa III. Animal models of oxyntic atrophy and metaplasia. Am J Physiol Gastrointest Liver Physiol 291 (2006) G999-G1004
9. Wang T.C., Goldenring J.R., Dangler C., et al. Mice lacking secretory phospholipase A2 show altered apoptosis and differentiation with Helicobacter felis infection. Gastroenterology 114 (1998) 675-689
10. Schmidt P.H., Lee J.R., Joshi V., et al. Identification of a metaplastic cell lineage associated with human gastric adenocarcinoma. Lab Invest 79 (1999) 639-646
11. Kang W., Rathinavelu S., Samuelson L.C., et al. Interferon gamma induction of gastric mucous neck cell hypertrophy. Lab Invest 85 (2005) 702-715
12. Oshima M., Oshima H., Matsunaga A., et al. Hyperplastic gastric tumors with spasmolytic polypeptide-expressing metaplasia caused by tumor necrosis factor-alpha-dependent inflammation in cyclooxygenase-2/microsomal prostaglandin E synthase-1 transgenic mice. Cancer Res 65 (2005) 9147-9151
13. Halldorsdottir A.M., Sigurdardottrir M., Jonasson J.G., et al. Spasmolytic polypeptide-expressing metaplasia (SPEM) associated with gastric cancer in Iceland. Dig Dis Sci 48 (2003) 431-441
14. Akagi M., Yokozaki H., Kitadai Y., et al. Expression of amphiregulin in human gastric cancer cell lines. Cancer 75 (1995) 1460-1466
15. Beauchamp R.D., Barnard J.A., McCutchen C.M., et al. Localization of transforming growth factor alpha and its receptor in gastric mucosal cells. Implications for a regulatory role in acid secretion and mucosal renewal. J Clin Invest 84 (1989) 1017-1023
16. Dempsey P.J., Goldenring J.R., Soroka C.J., et al. Possible role of transforming growth factor alpha in the pathogenesis of Ménétrier's disease: supportive evidence form humans and transgenic mice. Gastroenterology 103 (1992) 1950-1963
17. Murayama Y., Miyagawa J., Higashiyama S., et al. Localization of heparin-binding epidermal growth factor-like growth factor in human gastric mucosa. Gastroenterology 109 (1995) 1051-1059
18. Tang L.H., Modlin I.M., Lawton G.P., et al. The role of transforming growth factor alpha in the enterochromaffin-like cell tumor autonomy in an African rodent mastomys. Gastroenterology 111 (1996) 1212-1223
19. Nomura S., Settle S.H., Leys C.M., et al. Evidence for repatterning of the gastric fundic epithelium associated with Ménétrier's disease and TGFalpha overexpression. Gastroenterology 128 (2005) 1292-1305
20. Takaishi S., Cui G., Frederick D.M., et al. Synergistic inhibitory effects of gastrin and histamine receptor antagonists on Helicobacter-induced gastric cancer. Gastroenterology 128 (2005) 1965-1983
21. Katada K., Naito Y., Mizushima K., et al. Gene expression profiles on hypoxia and reoxygenation in rat gastric epithelial cells: a high-density DNA microarray analysis. Digestion 73 (2006) 89-100
22. Nam K.T., Varro A., Coffey R.J., et al. Potentiation of oxyntic atrophy-induced gastric metaplasia in amphiregulin-deficient mice. Gastroenterology 132 (2007) 1804-1819
23. Nomura S., Yamaguchi H., Ogawa M., et al. Alterations in gastric mucosal lineages induced by acute oxyntic atrophy in wild-type and gastrin-deficient mice. Am J Physiol Gastrointest Liver Physiol 288 (2005) G362-G375
24. Yamaguchi H., Goldenring J.R., Kaminishi M., et al. Identification of spasmolytic polypeptide expressing metaplasia (SPEM) in remnant gastric cancer and surveillance postgastrectomy biopsies. Dig Dis Sci 47 (2002) 573-578
25. Goldenring J.R., Ray G.S., Coffey R.J., et al. Reversible drug-induced oxyntic atrophy in rats. Gastroenterology 118 (2000) 1080-1093
26. Leys C.M., Nomura S., Rudzinski E., et al. Expression of Pdx-1 in human gastric metaplasia and gastric adenocarcinoma. Hum Pathol 37 (2006) 1162-1168
27. Guilford P., Hopkins J., Harraway J., et al. E-cadherin germline mutations in familial gastric cancer. Nature 392 (1998) 402-405
28. Guilford P.J., Hopkins J.B., Grady W.M., et al. E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer. Hum Mutat 14 (1999) 249-255
29. Kim H.S., Hong E.K., Park S.Y., et al. Expression of beta-catenin and E-cadherin in the adenoma-carcinoma sequence of the stomach. Anticancer Res 23 (2003) 2863-2868
30. Lowy A.M., Knight J., and Groden J. Restoration of E-cadherin/beta-catenin expression in pancreatic cancer cells inhibits growth by induction of apoptosis. Surgery 132 (2002) 141-148
31. Smith V.C., and Genta R.M. Role of Helicobacter pylori gastritis in gastric atrophy, intestinal metaplasia, and gastric neoplasia. Microsc Res Tech 48 (2000) 313-320
32. Dixon M.F., Genta R.M., Yardley J.H., et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 20 (1996) 1161-1181
33. Hattori T. Development of adenocarcinomas in the stomach. Cancer 57 (1986) 1528-1534
34. Silberg D.G., Sullivan J., Kang E., et al. Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice. Gastroenterology 122 (2002) 689-696
35. Mutoh H., Sakurai S., Satoh K., et al. Development of gastric carcinoma from intestinal metaplasia in Cdx2-transgenic mice. Cancer Res 64 (2004) 7740-7747
36. Yoshizawa N., Takenaka Y., Yamaguchi H., et al. Emergence of spasmolytic polypeptide-expressing metaplasia in Mongolian gerbils infected with Helicobacter pylori. Lab Invest 87 (2007) 1265-1276
37. Wright N.A., Pike C., and Elia G. Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cells. Nature 343 (1990) 82-85
38. Wright N.A., Poulsom R., Stamp G.W., et al. Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues. J Pathol 162 (1990) 279-284
39. Merchant J.L. Inflammation, atrophy, gastric cancer: connecting the molecular dots. Gastroenterology 129 (2005) 1079-1082
40. Wang T.C., Koh T.J., Varro A., et al. Processing and proliferative effects of human progastrin in transgenic mice. J Clin Invest 98 (1996) 1918-1929
41. Fox J.G., Blanco M., Murphy J.C., et al. Local and systemic immune responses in murine Helicobacter felis active chronic gastritis. Infect Immun 61 (1993) 2309-2315
42. Mohammadi M., Czinn S., Redline R., et al. Helicobacter-specific cell-mediated immune responses display a predominant Th1 phenotype and promote a delayed-type hypersensitivity response in the stomachs of mice. J Immunol 156 (1996) 4729-4738
43. Zaiss D.M., Yang L., Shah P.R., et al. Amphiregulin, a TH2 cytokine enhancing resistance to nematodes. Science 314 (2006) 1746
44. Luetteke N.C., Qiu T.H., Fenton S.E., et al. Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. Development 126 (1999) 2739-2750
45. Riese II D.J., Komurasaki T., Plowman G.D., et al. Activation of ErbB4 by the bifunctional epidermal growth factor family hormone epiregulin is regulated by ErbB2. J Biol Chem 273 (1998) 11288-11294